Review



hek 293 cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC hek 293 cells
    Cell viability <t>of</t> <t>HEK-293</t> cells treated with (a) chitosan GQDs (mint green), glucosamine hydrochloride GQDs (blue), ascorbic acid GQDs (pink), dextran GQDs (violet), sodium citrate GQDs (dark yellow), and sodium cholate GQDs (black) and (b) PEG GQDs (dark green), L-glutamic acid GQDs (light -blue), hyaluronic acid GQDs (orange), glucose GQDs (dark purple), and citric acid–urea GQDs (red), (c) and their highest biocompatible concentrations evaluated via the MTT assay.
    Hek 293 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 21861 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hek 293 cells/product/ATCC
    Average 99 stars, based on 21861 article reviews
    hek 293 cells - by Bioz Stars, 2026-05
    99/100 stars

    Images

    1) Product Images from "Precursor-dependent optical and structural properties of eleven NIR-emissive graphene quantum dots for bioimaging applications"

    Article Title: Precursor-dependent optical and structural properties of eleven NIR-emissive graphene quantum dots for bioimaging applications

    Journal: 2d Materials

    doi: 10.1088/2053-1583/ae4e41

    Cell viability of HEK-293 cells treated with (a) chitosan GQDs (mint green), glucosamine hydrochloride GQDs (blue), ascorbic acid GQDs (pink), dextran GQDs (violet), sodium citrate GQDs (dark yellow), and sodium cholate GQDs (black) and (b) PEG GQDs (dark green), L-glutamic acid GQDs (light -blue), hyaluronic acid GQDs (orange), glucose GQDs (dark purple), and citric acid–urea GQDs (red), (c) and their highest biocompatible concentrations evaluated via the MTT assay.
    Figure Legend Snippet: Cell viability of HEK-293 cells treated with (a) chitosan GQDs (mint green), glucosamine hydrochloride GQDs (blue), ascorbic acid GQDs (pink), dextran GQDs (violet), sodium citrate GQDs (dark yellow), and sodium cholate GQDs (black) and (b) PEG GQDs (dark green), L-glutamic acid GQDs (light -blue), hyaluronic acid GQDs (orange), glucose GQDs (dark purple), and citric acid–urea GQDs (red), (c) and their highest biocompatible concentrations evaluated via the MTT assay.

    Techniques Used: MTT Assay



    Similar Products

    99
    ATCC hek 293 cells
    Cell viability <t>of</t> <t>HEK-293</t> cells treated with (a) chitosan GQDs (mint green), glucosamine hydrochloride GQDs (blue), ascorbic acid GQDs (pink), dextran GQDs (violet), sodium citrate GQDs (dark yellow), and sodium cholate GQDs (black) and (b) PEG GQDs (dark green), L-glutamic acid GQDs (light -blue), hyaluronic acid GQDs (orange), glucose GQDs (dark purple), and citric acid–urea GQDs (red), (c) and their highest biocompatible concentrations evaluated via the MTT assay.
    Hek 293 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hek 293 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    hek 293 cells - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human embryonic kidney wt hek 293 cells
    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a <t>domain.</t> <t>HEK293</t> cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).
    Human Embryonic Kidney Wt Hek 293 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney wt hek 293 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney wt hek 293 cells - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    86
    Cyprotex Discovery human embryonic kidney hek 293 cells
    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a <t>domain.</t> <t>HEK293</t> cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).
    Human Embryonic Kidney Hek 293 Cells, supplied by Cyprotex Discovery, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek 293 cells/product/Cyprotex Discovery
    Average 86 stars, based on 1 article reviews
    human embryonic kidney hek 293 cells - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    99
    ATCC human embryonic kidney cell line hek 293
    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a <t>domain.</t> <t>HEK293</t> cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).
    Human Embryonic Kidney Cell Line Hek 293, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney cell line hek 293/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney cell line hek 293 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    86
    Procell Inc hek 293 t cells
    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a <t>domain.</t> <t>HEK293</t> cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).
    Hek 293 T Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hek 293 t cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    hek 293 t cells - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    99
    ATCC human embryonic kidney hek cells
    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a <t>domain.</t> <t>HEK293</t> cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).
    Human Embryonic Kidney Hek Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human embryonic kidney hek cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human embryonic kidney hek cells - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC hek 293 t cell line
    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a <t>domain.</t> <t>HEK293</t> cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).
    Hek 293 T Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hek 293 t cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    hek 293 t cell line - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    Image Search Results


    Cell viability of HEK-293 cells treated with (a) chitosan GQDs (mint green), glucosamine hydrochloride GQDs (blue), ascorbic acid GQDs (pink), dextran GQDs (violet), sodium citrate GQDs (dark yellow), and sodium cholate GQDs (black) and (b) PEG GQDs (dark green), L-glutamic acid GQDs (light -blue), hyaluronic acid GQDs (orange), glucose GQDs (dark purple), and citric acid–urea GQDs (red), (c) and their highest biocompatible concentrations evaluated via the MTT assay.

    Journal: 2d Materials

    Article Title: Precursor-dependent optical and structural properties of eleven NIR-emissive graphene quantum dots for bioimaging applications

    doi: 10.1088/2053-1583/ae4e41

    Figure Lengend Snippet: Cell viability of HEK-293 cells treated with (a) chitosan GQDs (mint green), glucosamine hydrochloride GQDs (blue), ascorbic acid GQDs (pink), dextran GQDs (violet), sodium citrate GQDs (dark yellow), and sodium cholate GQDs (black) and (b) PEG GQDs (dark green), L-glutamic acid GQDs (light -blue), hyaluronic acid GQDs (orange), glucose GQDs (dark purple), and citric acid–urea GQDs (red), (c) and their highest biocompatible concentrations evaluated via the MTT assay.

    Article Snippet: HEK-293 cells (CRL-1573, ATCC) were plated into a 96-well plate at a density of 5000 cells per well and incubated at 37.1 °C with 5% CO 2 for approximately 18 h. Next, the cells were pre-treated with different concentrations of GQDs prepared by serial dilution.

    Techniques: MTT Assay

    (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a domain. HEK293 cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).

    Journal: bioRxiv

    Article Title: Rap1b Activates Endosomal AC9 to Drive the Second cAMP Wave

    doi: 10.64898/2026.05.06.723328

    Figure Lengend Snippet: (A) Schematic representation of the AC9(1037)AC2 chimera, an AC9 backbone carrying the AC2 C2 domain. (B) Representative confocal immunofluorescence micrographs (anti–HA) showing the subcellular localization of the HA–tagged AC9(1037)AC2 chimera at rest and after ISO (30nM) stimulation. Dynasore (dyna; 70μM) was used to block endocytosis–related morphological changes. (C) Real–time cytosolic cAMP measurements in HC–1 cells expressing the AC9(1037)AC2 chimera and the H188 FRET sensor during ISO (30nM) stimulation followed by forskolin and IBMX (F+I; FK 20μM, IBMX 250μM). Traces represent normalized FRET ratios (R/R₀). (D) Dose–response (DR) effects of CAP1 overexpression (CAP1) or knockdown (sh–CAP1) (left) and Rap1b modulation by constitutively active Rap1b G12V or the GTPase–activating protein Rap1 GAP (right) on cAMP production in HC–1 cells expressing the AC9(1037)AC2 chimera stimulated with ISO (30nM). ΔR/R₀ (%) FRET responses were measured with the H188 sensor. (E) Microscale thermophoresis (MST) analysis of AC9–YFP binding to purified His–Gαs (left) or His–Rap1b–GTPγS (right) in vitro . (F) Representative pull–down assay showing interaction between Rap1b and the AC9 C2a domain. HEK293 cells were transfected with HA–Rap1b G12V , and lysates were incubated with Ni–NTA agarose beads loaded with His–tagged AC9 C2a. Complex formation was detected by immunoblotting with an HA–specific antibody. Representative experiment (n = 3). (G) MST analysis of His–GFP–Rap1b G12V binding to purified His–C1a or His–C2a domains in vitro . (H) Schematic representation of CAP1–Rap1b binding to the AC9 C2 domain. Traces (panel C) are shown as mean ± SEM; n ≥ 8 cells from ≥ 3 independent experiments. Significance was assessed at t = 20 min after ISO (vertical line) by one-way ANOVA with Dunnett’s multiple-comparisons test versus vector control. Absence of asterisks denotes non-significance. DR data (panels D, E, G); pooled from n=3 independent experiments) were fit by nonlinear regression to a four–parameter logistic equation to obtain EC₅₀ values with 95% confidence intervals (CI). Differences (vs. vector) were assessed by extra–sum–of–square; p-values reported in Fig. S2E (panel D). EC₅₀ values were 6.0 × 10⁻⁷ M for AC9::Gαs and 1.27 × 10⁻⁶ M for AC9::Rap1b (p < 0.0001) (panel E). EC₅₀ values were 6.56 × 10⁻⁵ M for C1a and 9.66 × 10⁻⁷ M for C2a (p < 0.0001) (panel G).

    Article Snippet: The rat hepatoma clonal cell line HC–1 (kindly provided by Dr. Elliot Ross, University of Texas Southwestern Medical Center), human embryonic kidney WT HEK–293 cells (ATCC CRL–1573; Manassas, VA), and HEK–293 ΔGαs (kindly provided by Asaka Inoue, Tohoku University, Japan) cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM; MT10013CM) supplemented with 10% fetal bovine serum (FBS; FB12999102), penicillin plus streptomycin (100 IU/mL and 100 μg/mL, respectively; 15140122), and L–glutamine (2 mM; 25030164) (All from Thermo Fisher Scientific).

    Techniques: Immunofluorescence, Blocking Assay, Expressing, Over Expression, Knockdown, Microscale Thermophoresis, Binding Assay, Purification, In Vitro, Pull Down Assay, Transfection, Incubation, Western Blot, Plasmid Preparation, Control